U.S. prices of Revlimid compared to prices in select countries 2020

In 2020, both the estimated U.S. net price and gross price for a one-month supply (28 capsules) of Revlimid Oral Capsule (10mg) were over four times higher than gross prices paid in Australia. In comparison, while less extreme, U.S. prices of Revlimid were still over 2.5 times higher than Canadian.Revlimid is an immunomodulatory drug used to treat Multiple Myeloma (blood cancer) or anemia in patients with myelodysplastic syndrome.This statistic shows Revlimid's net and gross prices in the United States compared to gross prices in Australia and Canada as of 2020.

2020年，美国Revlimid口服胶囊（10mg）一个月供应量（28粒）的预估净价和毛价均超过澳大利亚支付毛价的四倍。相比之下，虽然程度较轻，但美国Revlimid的价格仍高出加拿大超过2.5倍。Revlimid是一种免疫调节药物，用于治疗多发性骨髓瘤（血液癌症）或骨髓增生异常综合征患者的贫血。本统计数据展示了Revlimid在美国的净价和毛价与截至2020年的澳大利亚和加拿大毛价的对比。